Effect of Free Fatty Acids (FFA) on Androgen Precursors in Women
NCT00473603 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13
Last updated 2018-01-25
Summary
The purpose of this study is to determine whether free fatty acids modify the androgen levels in healthy young women.
Conditions
- Hyperandrogenism
- Glucocorticoid Metabolism
Interventions
- DRUG
-
lipid/heparin infusion
to perform an i.v. lipid heparin infusion infusion for 4 h
Sponsors & Collaborators
-
Charite University, Berlin, Germany
lead OTHER
Principal Investigators
-
Knut Mai, MD
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-12-31
- Primary Completion
- 2008-05-31
- Completion
- 2008-05-31
Countries
- Germany
Study Locations
More Related Trials
-
Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders
NCT04487925 ·Status: RECRUITING ·Phase: PHASE4
-
Short-Term Androgen Priming Before COS Using Aromatase Inhibitor and hCG During Early-Follicular-Phase GnRH Antagonist Administration - a Randomized Controlled Trial
NCT00286364 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of LH Supplementation on the Endometrial Gene Expression Profile in Poor Ovarian Responders
NCT05405686 ·Status: WITHDRAWN ·Phase: PHASE4
-
Aromatase Activity and Ovarian Growth Factors in African-American Versus Caucasian Women
NCT00334971 ·Status: UNKNOWN ·Phase: NA
-
The Exogenous Progesterone Free Luteal Phase After GnRHa Trigger - a Pilot Study in Normo-responder IVF Patients
NCT01980680 ·Status: COMPLETED ·Phase: PHASE4
-
Feasibility and Safety of Fasting in Fertility Treatment
NCT04942457 ·Status: COMPLETED ·Phase: NA
-
Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist Protocol
NCT01732068 ·Status: COMPLETED ·Phase: PHASE2
-
Single Dose FSH-GEX™ in Healthy Volunteers
NCT01354886 ·Status: COMPLETED ·Phase: PHASE1
-
Ovarian Response Prediction in In Vitro Fertilization (IVF) Patients
NCT01206803 ·Status: COMPLETED
-
Androgenic Profile Following Controlled Ovarian Stimulation
NCT02992808 ·Status: UNKNOWN ·Phase: PHASE4
-
Can Dormant Perimenopausal Ovarian Follicles Become FSH Responsive?
NCT01201226 ·Status: UNKNOWN ·Phase: NA
-
Cumulative Pregnancy Rate With Lower and Higher Gonadotropin Dose During IVF Among Poor Responders
NCT05103228 ·Status: COMPLETED ·Phase: NA
-
Clomiphene Citrate in Combination With Gonadotropins for Ovarian Stimulation in Women With Poor Ovarian Response.
NCT02237755 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Hormone Replacement in Young Women With Premature Ovarian Failure
NCT00001951 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Low Dose Gonadotropin Stimulation Protocol Vs High Dose Gonadotropin Protocol in Poor Responders
NCT06778733 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Efficacy and Safety of FSH-GEX™ in Comparison With 150 IU Gonal-f®
NCT01794208 ·Status: COMPLETED ·Phase: PHASE2
-
Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) Response to Low Dose Clomiphene Citrate in Normally Menstruating Fertile Women
NCT01340521 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Improving in Vitro Fertilization in Women With Poor Ovarian Response
NCT04024722 ·Status: UNKNOWN ·Phase: NA
-
Modified Natural Cycle Offers a Chance of Pregnancy in Patients With Poor Response and High Basal FSH
NCT00417157 ·Status: COMPLETED
-
Evaluation of Physiologic and Standard Sex Steroid Replacement Regimens in Women With Premature Ovarian Failure
NCT00732693 ·Status: COMPLETED ·Phase: PHASE4
-
Corifollitropin Alfa Followed by hpHMG in a Long GnRH Agonist Protocol for the Treatment of Poor Ovarian Responders
NCT01732094 ·Status: COMPLETED ·Phase: PHASE2
-
To Explore the Effect of GH Pretreatment on Clinical Outcomes in Patients With Low Ovarian Reserve
NCT04384783 ·Status: UNKNOWN
-
A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Combined Treatment of Lutropin Alpha and Recombinant Human Luteinizing Hormone in the Middle of the Controlled Ovarian Stimulation Follicular Phase in Women With Reduced Ovarian Reserve
NCT01110707 ·Status: COMPLETED ·Phase: PHASE2
-
Levels of Anti-Mullerian Hormone (AMH) During Ovarian Stimulation With Gonadotropins
NCT02237781 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Pheno- & Genotyping POF (WHO III)
NCT01411644 ·Status: UNKNOWN